Recipients
EFSD/Lilly European Diabetes Research Programme Grants



2009:

Hadi Al-Hasani - German Institute for Human Nutrition Potsdam-Rehbruecke  - Nuthetal, Germany 
Role of TBC1D1 in GLUT4 translocation

Miriam Cnop -  Free University Brussels, Belgium
Stress relief or anti-apoptotic defense?  Mechanisms of GLP-1 protection against lipotoxic endoplasmic reticulum stress in pancreatic beta cells

Yuval Dor - Hebrew University of Jerusalem, Israel
Control of pancreatic cell specification by Groucho/TLE-mediated transcriptional repression

Sylvie Guerder - Physiopathology Centre of Toulouse-Purpan, France

Study of the function of the protease TSSP, a protease that controls diabetogenic CD4 T cell development and autoimmune diabetes in the NOD mouse

Per-Anders Jansson - Sahlgrenska University Hospital - Gothenburg, Sweden
Muscle insulin resistance - from molecular mechanisms to lifestyle intervention

Daniel Konrad -
University Children's Hospital - Zurich, Switzerland

Regulation of glucose and energy homeostasis by fat tissue transplantation

Anna Krook - Karolinska Institutet - Stockholm, Sweden
Skeletal muscle molecular mechanisms mediating exercise benefits in type 2 diabetes mellitus

Charlotte Ling - Lund University - Malmö, Sweden
Impact of genetic and epigenetic factors on type 2 diabetes

Margit Mahlapuu - Lundberg Laboratory - Gothenburg, Sweden
Regulation of metabolic and inflammatory balance in liver and skeletal muscle by AMP-activated protein kinase

Michael Roden -
Heinrich-Heine University - Düsseldorf, Germany

Insulin resistance of mitochondria and the effect of insulin therapy in humans

Yakup Tanriver - University Hospital Freiburg, Germany
Redirecting naturally occurring regulatory T cells with chimeric antigen receptors to induce transplantation tolerance against pancreatic islet grafts

2008:

Peter Carmeliet - Flanders Institute for Biotechnology - Zwijnaarde, Belgium
Evaluation of the oxygen sensor prolyl 1 hydroxylase domain 1 (PHD1) protein as a novel anti-type 2 diabetic target

Miriam Cnop - Free University Brussels - Belgium
Mitochondrial dysfunction in insulin resistance and pancreatic beta cell failure - role in the pathogenesis of diabetes in Friedreich's ataxia

Stephan Herzig - Deutsches Krebsforschungszentrum Heidelberg - Germany
Hepatic inflammation through co-activator-dependent macrophage activation in obesity-related type 2 diabetes

Claes Wollheim - University of Geneva - Switzerland
Intervention studies to ameliorate ER stress in diabetes using animal and cell models of MODY3

2007:

Francesco Beguinot - University of Naples - Italy
Prep1(pKnox) gene function in type 2 diabetes

Ingo Leibiger - Karolinska Institutet - Sweden
Non-invasive in vivo imaging of pancreatic beta cell signal-transduction

Martine Vaxillaire - Institut Pasteur Lille - France
Post genome-wide association study and functional investigation of novel type 2 diabetes susceptibility genes (GWAFI-T2D)

Juleen Zierath - Karolinska Institutet - Sweden
Epigenetic modifications involved in insulin sensitivity in human skeletal muscle

2006:

Angelo Avogaro - University of Padova - Italy
The protein p66Shc and the alterations of endothelial progenitor cells in diabetes

Benoit Gauthier - University Medical Center - Geneva, Switzerland
Human blood monocytes as a source of surrogate beta cells for cellular therapy of type 1 diabetes; establishment of an optimal and reproducible protocol

Joanne Rasschaert - Brussels Free University - Belgium
The signal transduction of virus-induced beta cell death and insulitis

Michele Solimena - Dresden University of Technology - Germany
SUMOylation in beta cells

2005:

Jens Brüning - Cologne University - Germany
Role of insulin action in hypothalamic AgRP/NPY-expressing neurons in the regulation of energy homeostasis and gluconeogenesis

Sarah Ferber - Sheba Medical Center - Tel-Hashomer, Israel
Improving the therapeutic outcome of using liver to replace pancreatic b-cells function in adult human tissues

Patrick Schrauwen - Maastricht University - The Netherlands
Cardiac lipid content and energy status in type 2 diabetes mellitus

Peter Van Endert - Paris Necker Institute - France
Prediction and treatment of type 1 diabetes by CD8+ T cell islet epitopes in HLA-A2/NOD mice

2004:

Giovanni Camussi - Turin University - Italy
Role of monocyte chemoattractant protein-1 in diabetic nephropathy

Jorge Ferrer - Institute for Biomedical Research - Barcelona, Spain
A genetic model to study multipotent progenitors of the embryonic and adult pancreas

Concepción Mora Giral - Institute for Biomedical Research - Barcelona, Spain
Study of the immunological balance resulting from pancreating beta cell hyperplasia and autoaggressive lymphocytic invasion in the NOD/Cdk4R24C knockin mice. Tumor immunity in NOD (Non Obese Diabetic) Autoimmune-pronemurine model

Giorgio Sesti - Magna Graecia University - Catanzaro, Italy
Elucidation of the molecular mechanisms by which pro- and anti-infammatory molecules affect insulin signalling related to glucose metabolism in skeletal muscle cells and adipocytes

Nils Welsh - Uppsala University - Sweden
c-Abl, a mediator of beta-cell death?

2003:

Angelika Bierhaus - Heidelberg University - Germany
RAGE-dependent NF-κβ activation in the pathogenesis of diabetic neuropathy

Monica Montagnani - Bari University - Italy
Elucidation of adiponectin signalling pathways related to activation of endothelial nitric oxide synthase in the vasculature

Juleen Zierath - Karolinska Institute - Stockholm, Sweden
The role of Diacylglycerol Kinase Delta (DGKd) in the regulation of glucose homeostasis: novel signalling pathways involved in insulin resistance in type 2 diabetes mellitus